Abstract
The incidence of heart failure among children constitutes a major cause of sickness and mortality during their initial years of existence. Whereas well-established guidelines are present for managing heart failure in adults, a corresponding consensus for the pediatric group is lacking. Within a healthcare setting, it's of paramount importance to establish a correct diagnosis and identify the root cause for the most effective intervention. Primary interventions include diuretics and angiotensin-converting enzyme inhibitors, however, the utilization of beta-blockers and cardiac therapy devices is less common in pediatric cases as compared to adults. For severe conditions, heart transplant remains the go-to therapeutic choice. Additionally, left ventricular assist devices can be employed as a temporary solution awaiting transplantation (due to scarcity of organ donors), recovery (in instances of myocarditis), or a definitive solution (for patients with systemic disease).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Advance Research in Medical & Health Science (ISSN: 2208-2425)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
